GWS
BIVV

Glassman Wealth Services’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Glassman Wealth Services’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-47
Closed -$3K – 1034
2017
Q4 		$3K Sell
47
-2
-4% -$109 ﹤0.01% 481
2017
Q3 		$3K Sell
49
-12
-20% -$703 ﹤0.01% 407
2017
Q2 		$4K Hold
61
– – ﹤0.01% 386
2017
Q1 		$3K Buy
+61
New +$3K ﹤0.01% 437

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Glassman Wealth Services's BIVV Position: Q1 2018 in Review

Glassman Wealth Services sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 47 shares — an estimated $3K sold.

Glassman Wealth Services first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $4K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Glassman Wealth Services reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Glassman Wealth Services sold 47 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $3K.
  • Glassman Wealth Services first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Glassman Wealth Services's Bioverativ Inc. Common Stock position peaked at $4K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Glassman Wealth Services's 13F filing for Q1 2018, filed 1 May 2018.